what is glp-1 agonist therapy Clinical Focus on Agonists in Type 2 Diabetes Mellitus GLP-1 Medications for Weight Loss:
Description
Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc
FDA approves Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
Glucagon-like peptide-1 (GLP-1) is a hormone involved in glucose homeostasis and satiety regulation
Coverage of the drugs for weight loss would end on Oct
Once weekly subcutaneous injection, gradually titrated by your provider
